← Back to Search

3D MR Fingerprinting scan for Breast Cancer

N/A
Waitlist Available
Led By Holly Marshall, MD
Research Sponsored by Case Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years from start of study
Awards & highlights

Study Summary

This trial will test if new MRI methods can more accurately measure a person's response to chemo.

Eligible Conditions
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years from start of study
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years from start of study for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Longitudinal relaxation (T1) and transverse relaxation (T2) relaxation times of tumor and normal breast tissue.
Breast

Trial Design

1Treatment groups
Experimental Treatment
Group I: 3D MR Fingerprinting scanExperimental Treatment1 Intervention
Three separate 3D MR fingerprinting scans: Before the start of chemotherapy, 7-10 days after the first cycle of chemotherapy, and within 1 month of the end of chemotherapy treatment.

Find a Location

Who is running the clinical trial?

Case Comprehensive Cancer CenterLead Sponsor
452 Previous Clinical Trials
31,897 Total Patients Enrolled
54 Trials studying Breast Cancer
4,954 Patients Enrolled for Breast Cancer
Holly Marshall, MDPrincipal InvestigatorUniversity Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment in this trial still available to participants?

"According to the information on clinicaltrials.gov, this trial is not recruiting presently. The study was first posted January 14th 2019 and its entry was most recently revised June 6th 2022. While no new candidates are being sought for this trial at present, there are yet 2602 other medical studies that do require participants."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Role of Magnetic Resonance Fingerprinting and Quantitative MR Imaging in Breast Cancer
2019. "Role of Magnetic Resonance Fingerprinting and Quantitative MR Imaging in Breast Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03650803.
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top